Skip to content
10-K/A

Annual Report

U.S. STEM CELL, INC.

0001185185-22-000809

← back to feed
Filed
Jul 8, 2022 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Mar 31, 2022 571.63M sh
Operating Cash Flow FY 2021 · Dec 31, 2021 −$1.06M
Operating Cash Flow FY 2021 · Dec 31, 2020 −$478.89K
Cash And Equivalents FY 2021 · Dec 31, 2021 $39.39K
Cash And Equivalents FY 2021 · Dec 31, 2020 $18.57K
Stockholders Equity FY 2021 · Dec 31, 2021 −$12.77M
Stockholders Equity FY 2021 · Dec 31, 2020 −$11.58M
Stockholders Equity FY 2021 · Dec 31, 2019 −$9.48M
Current Liabilities FY 2021 · Dec 31, 2021 $12.04M
Current Liabilities FY 2021 · Dec 31, 2020 $10.85M
Total Liabilities FY 2021 · Dec 31, 2021 $12.82M
Total Liabilities FY 2021 · Dec 31, 2020 $11.67M
Current Assets FY 2021 · Dec 31, 2021 $51K
Current Assets FY 2021 · Dec 31, 2020 $88.15K
Total Assets FY 2021 · Dec 31, 2021 $51K
Total Assets FY 2021 · Dec 31, 2020 $88.15K
Sga Expense FY 2021 · Dec 31, 2021 $2.28M
Sga Expense FY 2021 · Dec 31, 2020 $2.61M
Rd Expense FY 2021 · Dec 31, 2021 $0
Net Income FY 2021 · Dec 31, 2021 −$3.29M
Net Income FY 2021 · Dec 31, 2020 −$2.89M
Operating Income FY 2021 · Dec 31, 2021 −$2.14M
Operating Income FY 2021 · Dec 31, 2020 −$2.4M
Gross Profit FY 2021 · Dec 31, 2021 $148.72K
Gross Profit FY 2021 · Dec 31, 2020 $212.97K
Cost Of Revenue FY 2021 · Dec 31, 2021 $52.03K
Cost Of Revenue FY 2021 · Dec 31, 2020 $64.12K
Revenue FY 2021 · Dec 31, 2021 $200.75K
Revenue FY 2021 · Dec 31, 2020 $277.09K